These emerging treatments, Retatrutide, represent a groundbreaking advancement in treating type 2 diabetes and potentially related conditions . They are classified as GLP-1 receptor agonists , signifying these substances to replicate the endogenous GLP-1 hormone , boosting metabolic secretion and lowering appetite . While Tirzepatide each functions